25-Hydroxy Vitamin D Test at Lahore PCR Lab

25-Hydroxy Vitamin D Test at Lahore PCR Lab

25-Hydroxy Vitamin D, clinically referred to as calcidiol, is the primary circulating form of vitamin D in the human body and serves as the definitive biomarker for evaluating overall vitamin D status. Vitamin D is a fat-soluble prohormone that plays an indispensable role in maintaining systemic calcium and phosphorus homeostasis, which is vital for skeletal mineralization, neuromuscular transmission, and diverse cellular functions. The body synthesizes vitamin D3 (cholecalciferol) endogenously when skin is exposed to ultraviolet B (UVB) solar radiation. Alternatively, vitamin D can be acquired through dietary sources or supplementation in two primary forms: vitamin D2 (ergocalciferol) and vitamin D3. Regardless of the source, vitamin D is biologically inactive and must undergo a two-step enzymatic activation process. The first step occurs in the liver, where the enzyme 25-hydroxylase converts vitamin D into 25-hydroxyvitamin D [25(OH)D]. This is the specific molecule measured by the 25-Hydroxy Vitamin D test at Lahore PCR Lab in Lahore, Pakistan. The second hydroxylation step occurs primarily in the kidneys, where 25(OH)D is converted by the enzyme 1-alpha-hydroxylase into 1,25-dihydroxyvitamin D [1,25(OH)2D], also known as calcitriol, which is the biologically active hormone. Because 25-hydroxyvitamin D has a long circulating half-life of approximately 15 to 20 days and its concentration directly reflects both dietary intake and cutaneous synthesis, it is the single best indicator of vitamin D sufficiency, insufficiency, deficiency, or toxicity. At Lahore PCR Lab, we utilize advanced chemiluminescent immunoassay (CLIA) technology to deliver highly precise, reproducible, and clinically validated measurements of total 25-hydroxyvitamin D, encompassing both the D2 and D3 fractions. This level of diagnostic accuracy is critical for clinicians in Lahore and across Pakistan to diagnose metabolic bone diseases, monitor therapeutic supplementation, and manage chronic conditions associated with vitamin D dysregulation.

Clinical Procedure: What to Expect

Patient Preparation

• Avoid Biotin Supplements: It is highly recommended to avoid taking high-dose biotin (Vitamin B7) supplements for at least 72 hours prior to the blood draw. Biotin can significantly interfere with the streptavidin-biotin binding mechanisms used in modern laboratory immunoassays, potentially causing falsely elevated or falsely depressed results.
• Fasting Guidelines: While strict fasting is generally not mandatory for a standalone 25-hydroxy vitamin D test, patients are often advised to fast for 4 to 8 hours if their physician has ordered concurrent tests, such as a lipid profile, fasting blood glucose, or serum calcium.
• Medication Disclosure: Patients must inform their healthcare provider and the laboratory staff of all prescription medications, over-the-counter drugs, and dietary supplements they are currently taking, particularly calcium, vitamin D, or antiepileptic medications, as these can influence circulating levels or metabolic pathways.
• Hydration: Staying well-hydrated by drinking plenty of water before the procedure is encouraged, as it makes venipuncture easier and more comfortable.

During the Procedure

The 25-Hydroxy Vitamin D test is a standard venipuncture procedure performed by the highly trained phlebotomists at Lahore PCR Lab. Upon arrival, the patient is comfortably seated, and the phlebotomist verifies their identity and the requested test. The phlebotomist inspects the patient’s arm to select an appropriate vein, typically the median cubital vein located in the antecubital fossa (the bend of the elbow). The area is thoroughly cleansed with an antiseptic alcohol swab and allowed to air dry to prevent contamination. A sterile tourniquet is applied a few inches above the selected site to temporarily restrict venous blood flow, making the vein more prominent and easier to access. Using a sterile, single-use needle attached to a vacuum collection tube, the phlebotomist gently inserts the needle into the vein. Patients may feel a brief, mild pinch or stinging sensation. Blood is drawn into a gold-top serum separator tube (SST) or a red-top tube. Once the required volume of blood is collected, the tourniquet is released, the needle is smoothly withdrawn, and a sterile cotton ball or gauze is immediately applied to the puncture site with gentle pressure to promote hemostasis. A small adhesive bandage is placed over the site. The entire procedure takes less than five minutes. The collected specimen is then labeled with unique patient identifiers and sent to the biochemistry department for processing, where it is centrifuged to separate the serum from the cellular components before analysis.

When is a 25-Hydroxy Vitamin D Test Performed?

Evaluation of Bone Disorders and Osteoporosis

Metabolic bone diseases such as osteoporosis and osteopenia are characterized by compromised bone strength and an increased risk of fragility fractures. Vitamin D is essential for the active transport of dietary calcium and phosphorus across the intestinal mucosa. When vitamin D levels are inadequate, the body cannot absorb sufficient calcium, leading to the mobilization of calcium from the skeletal reservoir to maintain normal serum levels. This process, mediated by increased parathyroid hormone secretion, accelerates bone resorption and weakens the skeletal architecture. Physicians at Lahore PCR Lab frequently order the 25-Hydroxy Vitamin D test for postmenopausal women, elderly men, and individuals with a history of low-impact fractures to assess bone health, guide therapeutic interventions with calcium and vitamin D, and monitor the efficacy of anti-resorptive or anabolic osteoporosis medications.

Investigation of Chronic Fatigue and Muscle Weakness

Vitamin D receptors (VDR) are widely distributed throughout human skeletal muscle tissue, indicating that vitamin D plays a direct physiological role in muscle function, protein synthesis, and contractility. Patients suffering from chronic, unexplained fatigue, generalized muscle weakness, and diffuse musculoskeletal pain often present with underlying vitamin D deficiency. This deficiency can impair mitochondrial function within muscle cells, leading to decreased energy production and physical exhaustion. By measuring 25-hydroxyvitamin D levels, clinicians can differentiate between primary neuromuscular disorders, chronic fatigue syndrome, and easily treatable hypovitaminosis D. Restoring optimal vitamin D levels in these patients frequently results in significant improvements in muscle strength, physical performance, and overall energy levels.

Monitoring Malabsorption Syndromes

Vitamin D is a fat-soluble vitamin, meaning its absorption from the gastrointestinal tract is entirely dependent on the body’s ability to digest and absorb dietary lipids. Consequently, individuals diagnosed with gastrointestinal disorders that cause malabsorption are at an exceptionally high risk of developing severe vitamin D deficiency. These conditions include celiac disease, Crohn’s disease, ulcerative colitis, cystic fibrosis, chronic pancreatitis, and short bowel syndrome. Additionally, patients who have undergone bariatric surgeries, such as gastric bypass, often experience impaired nutrient absorption. Physicians routinely utilize the 25-Hydroxy Vitamin D test at Lahore PCR Lab to monitor these high-risk patients, determine the necessity of high-dose oral or intramuscular vitamin D therapy, and evaluate the effectiveness of absorption-promoting strategies.

Assessment of Chronic Kidney and Liver Diseases

The liver and kidneys are the primary organs responsible for the metabolic activation of vitamin D. Chronic hepatic diseases, such as cirrhosis, non-alcoholic fatty liver disease (NAFLD), or hepatitis, can severely impair the liver’s ability to perform the initial hydroxylation of vitamin D into 25-hydroxyvitamin D. Similarly, chronic kidney disease (CKD) impairs the renal conversion of 25(OH)D into its active form, 1,25-dihydroxyvitamin D, leading to a complex metabolic disorder known as renal osteodystrophy. Monitoring 25-hydroxyvitamin D levels in patients with renal or hepatic impairment is critical for clinicians to manage mineral and bone disorder syndromes, adjust active vitamin D analog therapies, and prevent secondary hyperparathyroidism.

Screening for Unexplained Bone Pain and Skeletal Deformities

Severe, prolonged vitamin D deficiency leads to defective mineralization of the newly formed bone matrix. In children, this condition is known as rickets and manifests as skeletal deformities, such as bowed legs, knock-knees, and delayed growth. In adults, the condition is termed osteomalacia and presents as deep, aching bone pain, localized bone tenderness, and an increased susceptibility to pseudofractures. Because the symptoms of osteomalacia can be subtle and easily misdiagnosed as fibromyalgia or arthritis, the 25-Hydroxy Vitamin D test is an essential diagnostic tool. Measuring calcidiol levels allows physicians to confirm defective mineralization, initiate aggressive vitamin D repletion protocols, and monitor the resolution of skeletal pathology.

What Does a 25-Hydroxy Vitamin D Test Detect?

• Severe Vitamin D Deficiency: Serum levels below 10 ng/mL, indicating a critical lack of vitamin D that puts the patient at high risk for rickets or osteomalacia.
• Moderate Vitamin D Deficiency: Serum levels between 10 and 20 ng/mL, which can lead to secondary hyperparathyroidism and accelerated bone loss.
• Vitamin D Insufficiency: Serum levels between 21 and 29 ng/mL, representing suboptimal levels that may impair calcium absorption and long-term skeletal health.
• Optimal Vitamin D Sufficiency: Serum levels between 30 and 100 ng/mL, indicating adequate stores for bone, muscle, and immune health.
• Vitamin D Toxicity or Hypervitaminosis D: Serum levels exceeding 100 ng/mL, particularly above 150 ng/mL, which can lead to life-threatening hypercalcemia.
• Secondary Hyperparathyroidism: A compensatory mechanism where the parathyroid glands overproduce PTH in response to low calcium levels caused by vitamin D deficiency.
• Impaired Intestinal Calcium Absorption: Resulting directly from insufficient circulating calcitriol.
• Increased Risk of Senile Osteoporosis: Characterized by age-related decline in bone density and microarchitectural deterioration.
• Postmenopausal Osteoporosis Risk: Exacerbated by estrogen deficiency and concurrent low vitamin D levels.
• Hypocalcemia: Low blood calcium levels, which can manifest as muscle cramps, spasms, and cardiac arrhythmias in severe deficiency states.
• Hypophosphatemia: Low blood phosphorus levels, often observed in conjunction with severe vitamin D deficiency and elevated PTH.
• Elevated Serum Alkaline Phosphatase (ALP): A biochemical marker of increased bone turnover associated with osteomalacia and rickets.
• Malabsorption-Induced Vitamin D Depletion: Secondary to gastrointestinal pathology such as celiac disease or inflammatory bowel disease.
• Hepatic-Induced Hydroxylation Failure: Resulting from advanced liver disease impairing the synthesis of 25-hydroxyvitamin D.
• Renal Osteodystrophy Risk: In patients with chronic kidney disease who cannot convert vitamin D to its active form.
• Pediatric Rickets: Characterized by growth plate abnormalities and skeletal deformities in children.
• Adult Osteomalacia: Presenting as diffuse bone pain and tenderness due to unmineralized osteoid.
• Increased Susceptibility to Fragility Fractures: Particularly of the hip, spine, and wrist.
• Myopathy and Proximal Muscle Weakness: Leading to an increased risk of falls, especially in elderly populations.
• Drug-Induced Vitamin D Deficiency: Caused by medications like anticonvulsants (e.g., phenytoin, phenobarbital) that accelerate vitamin D catabolism.
• Granulomatous Disease-Associated Dysregulation: Such as in sarcoidosis or tuberculosis, where extra-renal conversion of vitamin D can lead to hypercalcemia.
• Idiopathic Hypercalcemia of Infancy: A rare genetic disorder associated with hypersensitivity to vitamin D.
• Hypoparathyroidism-Related Vitamin D Resistance: Where lack of PTH impairs the activation of vitamin D.
• Pseudohypoparathyroidism: A genetic disorder characterized by target organ resistance to PTH, affecting vitamin D metabolism.
• Nutritional Vitamin D Deficiency: Arising from inadequate dietary intake and insufficient sunlight exposure, common in urban populations.

Turnaround Time and Report Access at Lahore PCR Lab

Lahore PCR Lab, located in Lahore, Pakistan, is dedicated to providing rapid, accurate, and accessible diagnostic services. Once the blood sample is collected, it is immediately transported to our advanced, temperature-controlled biochemistry department. Our laboratory utilizes fully automated chemiluminescent immunoassay analyzers that undergo daily calibration and strict quality control checks. The turnaround time for the 25-Hydroxy Vitamin D test is typically within 12 to 24 hours from the time of sample collection. Patients and referring physicians are notified via SMS as soon as the report is finalized. To ensure maximum convenience, Lahore PCR Lab offers multiple ways to access reports. Patients can securely view and download their digital reports through our official online portal or receive them directly on their registered WhatsApp number. Physical copies of the report can also be collected from our main laboratory or any of our official collection centers across Lahore. Every report is thoroughly reviewed and signed by our consultant pathologists to guarantee clinical validity.

25-Hydroxy Vitamin D Test Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
25-Hydroxyvitamin D Total (Serum)	30.0 – 100.0 ng/mL	<20.0 ng/mL (Deficiency); 20.0 – 29.0 ng/mL (Insufficiency); >100.0 ng/mL (Toxicity)
Serum Calcium	8.5 – 10.2 mg/dL	<8.5 mg/dL (Hypocalcemia due to severe deficiency); >10.2 mg/dL (Hypercalcemia due to toxicity)
Serum Phosphorus	2.5 – 4.5 mg/dL	<2.5 mg/dL (Hypophosphatemia associated with rickets/osteomalacia); >4.5 mg/dL (Hyperphosphatemia in renal failure)
Parathyroid Hormone (PTH)	10 – 65 pg/mL	>65 pg/mL (Secondary Hyperparathyroidism compensatory to low vitamin D)
Alkaline Phosphatase (ALP)	44 – 147 IU/L	>147 IU/L (Elevated bone turnover in osteomalacia or rickets)
25-Hydroxyvitamin D2 (Ergocalciferol)	Variable (reflects dietary/supplement intake)	Low or undetectable levels indicating lack of plant-based vitamin D intake
25-Hydroxyvitamin D3 (Cholecalciferol)	Variable (reflects sun exposure/supplement intake)	Low levels indicating inadequate solar exposure or animal-based vitamin D intake
Serum Creatinine	0.6 – 1.2 mg/dL	>1.2 mg/dL (Impaired renal function affecting active vitamin D synthesis)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Lahore PCR Lab for 25-Hydroxy Vitamin D Test?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified consultant pathologists, biochemists, and skilled phlebotomists.
• Patient-Focused Care: We prioritize patient comfort and safety throughout the entire testing process.
• Quality Diagnostic Services: We adhere to strict internal and external quality assurance protocols to ensure clinical accuracy.
• Professional Reporting: Every test report is meticulously validated and signed by a consultant pathologist.
• Modern Diagnostic Approach: We utilize state-of-the-art automated chemiluminescent immunoassay (CLIA) technology.
• Comfortable Environment: Our collection centers are designed to provide a clean, hygienic, and welcoming environment.
• Convenient Location: Located centrally in Lahore, Pakistan, making it easily accessible for all residents.
• Commitment to Accurate Diagnosis: We are dedicated to providing reliable and timely results to support clinical decision-making.